NANOLEK LLC products

Biotechnology Products

HUNTERASE - Drug for the Long-Term Treatment of Patients with Hunter Syndrome

HUNTERASE® is indicated for the long-term treatment of patients with Hunter syndrome (mucopolysaccharidosis type II, MPS II)

FLAMMEGIS - Anti-Tumor Necrosis Factor-Alpha Monoclonalantibody

Anti-tumor necrosis factor-alpha monoclonalantibody. Effective in rheumathoid arthritis, Crohn`s disease, ulcerative colitis, psoriasis, ankylosing spondylitis.